Literature DB >> 34494711

Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease.

Adam Martersteck1,2, Jaiashre Sridhar1, Christina Coventry1, Sandra Weintraub1,3, M-Marsel Mesulam1,4, Emily Rogalski1,3.   

Abstract

INTRODUCTION: Examination of pathologic, anatomic, and cognitive relationships has been limited in primary progressive aphasia (PPA) with underlying Alzheimer's disease (AD) neuropathology.
METHODS: Spatial relationships between tau positron emission tomography (PET), cortical thickness, age, and naming on the Boston Naming Test (BNT) in PPA with biomarker evidence of AD (PPA-AD) were examined.
RESULTS: Higher tau PET burden was associated with atrophy and younger age. There was a significant left-lateralized relationship between lower BNT and more atrophy, and between lower BNT and increased tau burden. Variance in naming was primarily shared between tau and atrophy (51%), but naming was uniquely explained more by atrophy (32%) than tau (16%). Higher left anterior temporal tau burden was associated with greater 1-year rate of decline in naming. DISCUSSION: PPA-AD has a similar relationship between abnormal biomarkers as first described in amnestic AD, with differing spatial extent, reflecting the left-lateralized nature of the language network.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  AV-1451; atrophy; cortical thickness; magnetic resonance imaging; naming; positron emission tomography; primary progressive aphasia; tau positron emission tomography; volumetric magnetic resonance imaging

Mesh:

Substances:

Year:  2021        PMID: 34494711      PMCID: PMC8648928          DOI: 10.1002/alz.12445

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  47 in total

1.  Anatomy of language impairments in primary progressive aphasia.

Authors:  Emily Rogalski; Derin Cobia; Theresa M Harrison; Christina Wieneke; Cynthia K Thompson; Sandra Weintraub; M-Marsel Mesulam
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

2.  Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration.

Authors:  Corey T McMillan; David J Irwin; Ilya Nasrallah; Jeffrey S Phillips; Meredith Spindler; Katya Rascovsky; Kylie Ternes; Charles Jester; David A Wolk; Linda K Kwong; Virginia M-Y Lee; Edward B Lee; John Q Trojanowski; Murray Grossman
Journal:  Acta Neuropathol       Date:  2016-11-04       Impact factor: 17.088

3.  Clinical and cortical decline in the aphasic variant of Alzheimer's disease.

Authors:  Emily Joy Rogalski; Jaiashre Sridhar; Adam Martersteck; Benjamin Rader; Derin Cobia; Anupa K Arora; Angela J Fought; Eileen H Bigio; Sandra Weintraub; Marek-Marsel Mesulam; Alfred Rademaker
Journal:  Alzheimers Dement       Date:  2019-02-11       Impact factor: 21.566

4.  Words and objects at the tip of the left temporal lobe in primary progressive aphasia.

Authors:  M-Marsel Mesulam; Christina Wieneke; Robert Hurley; Alfred Rademaker; Cynthia K Thompson; Sandra Weintraub; Emily J Rogalski
Journal:  Brain       Date:  2013-01-29       Impact factor: 13.501

5.  Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.

Authors:  Daniel T Ohm; Angela J Fought; Alfred Rademaker; Garam Kim; Jaiashre Sridhar; Christina Coventry; Tamar Gefen; Sandra Weintraub; Eileen Bigio; Marek Marsel Mesulam; Emily Rogalski; Changiz Geula
Journal:  Brain Pathol       Date:  2019-09-12       Impact factor: 6.508

6.  The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Peter Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Stephen D Weigand; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2019-03-08       Impact factor: 21.566

Review 7.  A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.

Authors:  Saima Rathore; Mohamad Habes; Muhammad Aksam Iftikhar; Amanda Shacklett; Christos Davatzikos
Journal:  Neuroimage       Date:  2017-04-13       Impact factor: 6.556

8.  Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

Authors:  Alexandre Bejanin; Daniel R Schonhaut; Renaud La Joie; Joel H Kramer; Suzanne L Baker; Natasha Sosa; Nagehan Ayakta; Averill Cantwell; Mustafa Janabi; Mariella Lauriola; James P O'Neil; Maria L Gorno-Tempini; Zachary A Miller; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

9.  Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Suzanne L Baker; Jesse A Brown; Viktoriya Bourakova; Jungho Cha; Kiran Chaudhary; Lauren Edwards; Leonardo Iaccarino; Mustafa Janabi; Orit H Lesman-Segev; Zachary A Miller; David C Perry; James P O'Neil; Julie Pham; Julio C Rojas; Howard J Rosen; William W Seeley; Richard M Tsai; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Sci Transl Med       Date:  2020-01-01       Impact factor: 17.956

10.  Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.

Authors:  Leonardo Iaccarino; Gautam Tammewar; Nagehan Ayakta; Suzanne L Baker; Alexandre Bejanin; Adam L Boxer; Maria Luisa Gorno-Tempini; Mustafa Janabi; Joel H Kramer; Andreas Lazaris; Samuel N Lockhart; Bruce L Miller; Zachary A Miller; James P O'Neil; Rik Ossenkoppele; Howard J Rosen; Daniel R Schonhaut; William J Jagust; Gil D Rabinovici
Journal:  Neuroimage Clin       Date:  2017-09-25       Impact factor: 4.881

View more
  1 in total

1.  Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology.

Authors:  Adam Martersteck; Ivan Ayala; Daniel T Ohm; Callen Spencer; Christina Coventry; Sandra Weintraub; Eileen H Bigio; M -Marsel Mesulam; Changiz Geula; Emily Rogalski
Journal:  Acta Neuropathol Commun       Date:  2022-08-09       Impact factor: 7.578

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.